Clinical Trial Update: Study of MDX-010 in Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of MDX-010 in stage IV breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Breast Cancer

Drugs mentioned

• MDX-010 (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer, Adenocarcinoma | Phase 2 | Status: COMPLETED